Galaxy | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

123 results for “Galaxy”

Trials

View all 54 →

The GALAXY-1 Project

8 participants · First posted Aug 14, 2023

Samsung Galaxy Watch Body Composition Study

110 participants · First posted Feb 1, 2022

Neoadjuvant Nivolumab Plus Ipilimumab in Resectable NSCLC (GALAXY 3)

69 participants · First posted Apr 15, 2025

Drugs

View all 11 →

humanized mAbs (Galaxy Biotech)

Anti-HGF monoclonal antibody L2G7(Galaxy Biotech)

Indolocarbazoles (Glaxo Wellcome)

Organizations

View all 16 →

Galaxy Therapeutics, Inc.

United States

GALAXY IMPORT & EXPORT CO. PTY. LTD.

Australia

NUI Galway

Ireland

News

View all 42 →

AimedBio Invests $1.5 Million in Galaxy for AI-Designed Brain-Penetrating Antibody Development

ONL Therapeutics Initiates Phase 2 GALAXY Trial for Xelafaslatide in Geographic Atrophy

Samsung Galaxy Buds Gain FDA Clearance for Over-the-Counter Hearing Aid Feature

Page 1 of 13